Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Balancing yield with tax efficiency in a bond ladder helps you capture higher after-tax income while managing interest-rate risk and withdrawals.
28,391 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
A stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...